vs

Side-by-side financial comparison of RE/MAX Holdings, Inc. (RMAX) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $41.8M, roughly 1.7× Neuronetics, Inc.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -17.2%, a 19.3% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -4.7%).

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

RMAX vs STIM — Head-to-Head

Bigger by revenue
RMAX
RMAX
1.7× larger
RMAX
$71.1M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+87.6% gap
STIM
85.7%
-1.8%
RMAX
Higher net margin
RMAX
RMAX
19.3% more per $
RMAX
2.0%
-17.2%
STIM
More free cash flow
RMAX
RMAX
$32.8M more FCF
RMAX
$33.5M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-4.7%
RMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RMAX
RMAX
STIM
STIM
Revenue
$71.1M
$41.8M
Net Profit
$1.4M
$-7.2M
Gross Margin
52.0%
Operating Margin
13.1%
-12.1%
Net Margin
2.0%
-17.2%
Revenue YoY
-1.8%
85.7%
Net Profit YoY
-75.2%
43.2%
EPS (diluted)
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMAX
RMAX
STIM
STIM
Q4 25
$71.1M
$41.8M
Q3 25
$73.2M
$37.3M
Q2 25
$72.8M
$38.1M
Q1 25
$74.5M
$32.0M
Q4 24
$72.5M
$22.5M
Q3 24
$78.5M
$18.5M
Q2 24
$78.5M
$16.4M
Q1 24
$78.3M
$17.4M
Net Profit
RMAX
RMAX
STIM
STIM
Q4 25
$1.4M
$-7.2M
Q3 25
$4.0M
$-9.0M
Q2 25
$4.7M
$-10.1M
Q1 25
$-2.0M
$-12.7M
Q4 24
$5.8M
$-12.7M
Q3 24
$966.0K
$-13.3M
Q2 24
$3.7M
$-9.8M
Q1 24
$-3.4M
$-7.9M
Gross Margin
RMAX
RMAX
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
RMAX
RMAX
STIM
STIM
Q4 25
13.1%
-12.1%
Q3 25
25.0%
-19.6%
Q2 25
19.3%
-21.1%
Q1 25
7.2%
-34.4%
Q4 24
5.9%
-51.0%
Q3 24
19.4%
-41.7%
Q2 24
20.6%
-51.7%
Q1 24
5.8%
-39.4%
Net Margin
RMAX
RMAX
STIM
STIM
Q4 25
2.0%
-17.2%
Q3 25
5.4%
-24.3%
Q2 25
6.4%
-26.6%
Q1 25
-2.6%
-39.6%
Q4 24
8.0%
-56.4%
Q3 24
1.2%
-72.0%
Q2 24
4.7%
-59.8%
Q1 24
-4.3%
-45.2%
EPS (diluted)
RMAX
RMAX
STIM
STIM
Q4 25
$-0.10
Q3 25
$-0.13
Q2 25
$-0.15
Q1 25
$-0.21
Q4 24
$-0.34
Q3 24
$-0.44
Q2 24
$-0.33
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMAX
RMAX
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$118.7M
$28.1M
Total DebtLower is stronger
$432.2M
$65.8M
Stockholders' EquityBook value
$452.4M
$22.4M
Total Assets
$582.5M
$141.6M
Debt / EquityLower = less leverage
0.96×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMAX
RMAX
STIM
STIM
Q4 25
$118.7M
$28.1M
Q3 25
$107.5M
$28.0M
Q2 25
$94.3M
$11.0M
Q1 25
$89.1M
$20.2M
Q4 24
$96.6M
$18.5M
Q3 24
$83.8M
$20.9M
Q2 24
$66.1M
$42.6M
Q1 24
$82.1M
$47.7M
Total Debt
RMAX
RMAX
STIM
STIM
Q4 25
$432.2M
$65.8M
Q3 25
$433.3M
$65.7M
Q2 25
$434.4M
$55.5M
Q1 25
$435.3M
$55.3M
Q4 24
$436.2M
$55.2M
Q3 24
$437.2M
$46.0M
Q2 24
$438.1M
$59.8M
Q1 24
$439.0M
$59.4M
Stockholders' Equity
RMAX
RMAX
STIM
STIM
Q4 25
$452.4M
$22.4M
Q3 25
$448.1M
$27.4M
Q2 25
$442.4M
$27.1M
Q1 25
$433.5M
$35.5M
Q4 24
$429.5M
$27.7M
Q3 24
$423.1M
$9.4M
Q2 24
$418.4M
$19.4M
Q1 24
$412.0M
$27.7M
Total Assets
RMAX
RMAX
STIM
STIM
Q4 25
$582.5M
$141.6M
Q3 25
$582.2M
$145.5M
Q2 25
$574.8M
$134.7M
Q1 25
$571.4M
$142.0M
Q4 24
$581.6M
$140.9M
Q3 24
$578.6M
Q2 24
$571.4M
$96.8M
Q1 24
$566.7M
$103.8M
Debt / Equity
RMAX
RMAX
STIM
STIM
Q4 25
0.96×
2.94×
Q3 25
0.97×
2.40×
Q2 25
0.98×
2.05×
Q1 25
1.00×
1.56×
Q4 24
1.02×
1.99×
Q3 24
1.03×
4.90×
Q2 24
1.05×
3.08×
Q1 24
1.07×
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMAX
RMAX
STIM
STIM
Operating Cash FlowLast quarter
$40.9M
$908.0K
Free Cash FlowOCF − Capex
$33.5M
$692.0K
FCF MarginFCF / Revenue
47.1%
1.7%
Capex IntensityCapex / Revenue
10.4%
0.5%
Cash ConversionOCF / Net Profit
28.39×
TTM Free Cash FlowTrailing 4 quarters
$56.8M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMAX
RMAX
STIM
STIM
Q4 25
$40.9M
$908.0K
Q3 25
$17.7M
$-785.0K
Q2 25
$4.6M
$-3.5M
Q1 25
$5.7M
$-17.0M
Q4 24
$59.7M
$-8.6M
Q3 24
$17.6M
$-5.4M
Q2 24
$15.9M
$-5.0M
Q1 24
$9.4M
$-12.0M
Free Cash Flow
RMAX
RMAX
STIM
STIM
Q4 25
$33.5M
$692.0K
Q3 25
$16.4M
$-899.0K
Q2 25
$2.9M
$-3.8M
Q1 25
$4.0M
$-17.2M
Q4 24
$53.0M
$-8.7M
Q3 24
$16.3M
$-5.8M
Q2 24
$14.0M
$-5.6M
Q1 24
$6.8M
$-12.4M
FCF Margin
RMAX
RMAX
STIM
STIM
Q4 25
47.1%
1.7%
Q3 25
22.4%
-2.4%
Q2 25
4.0%
-9.9%
Q1 25
5.3%
-53.8%
Q4 24
73.2%
-38.6%
Q3 24
20.8%
-31.3%
Q2 24
17.8%
-34.0%
Q1 24
8.6%
-71.1%
Capex Intensity
RMAX
RMAX
STIM
STIM
Q4 25
10.4%
0.5%
Q3 25
1.8%
0.3%
Q2 25
2.2%
0.7%
Q1 25
2.3%
0.7%
Q4 24
9.1%
0.4%
Q3 24
1.7%
2.1%
Q2 24
2.4%
3.7%
Q1 24
3.3%
2.2%
Cash Conversion
RMAX
RMAX
STIM
STIM
Q4 25
28.39×
Q3 25
4.45×
Q2 25
0.97×
Q1 25
Q4 24
10.28×
Q3 24
18.22×
Q2 24
4.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

STIM
STIM

Segment breakdown not available.

Related Comparisons